Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Clinical trial NCT03272633 · TERMINATED

Trial details

NCT number: NCT03272633
Sponsor: Rutgers, The State University of New Jersey
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia in Remission Hematopoietic Cell Transplantation Recipient JAK2 Gene Mutation Loss of Chromosome 17p Mantle Cell Lymphoma Minimal Residual Disease Myelodysplastic Syndrome Non-Hodgkin Lymphoma Plasma Cell Myeloma RAS Family Gene Mutation Recurrent Diffuse Large B-Cell Lymphoma

Start date: 2020-10-26
Primary completion: 2022-06-30
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.